Page last updated: 2024-08-21

isoxazoles and Hepatitis

isoxazoles has been researched along with Hepatitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callado, MR; Vieira, FJ; Vieira, WP1
Chen, JQ; Li, J; Xu, SY; Yao, HW2
Asano, T; Hayashi, H; Imao, M; Imose, M; Kimura, K; Moriwaki, H; Nagaki, M; Naiki, T; Osawa, Y; Takai, S1

Other Studies

4 other study(ies) available for isoxazoles and Hepatitis

ArticleYear
Abatacept as an option therapy in difficult to treat psoriatic arthritis.
    Rheumatology international, 2010, Volume: 30, Issue:6

    Topics: Abatacept; Arthritis, Psoriatic; Drug Administration Schedule; Drug Resistance; Female; Hepatitis; Humans; Immunoconjugates; Immunosuppressive Agents; Isoniazid; Isoxazoles; Joints; Leflunomide; Leg; Methotrexate; Middle Aged; Nucleic Acid Synthesis Inhibitors; Skin; Treatment Outcome; Tumor Necrosis Factor-alpha

2010
Leflunomide attenuates hepatocyte injury by inhibiting Kupffer cells.
    World journal of gastroenterology, 2004, Jun-01, Volume: 10, Issue:11

    Topics: Aniline Compounds; Animals; Cell Communication; Cells, Cultured; Crotonates; Hepatitis; Hepatocytes; Hydroxybutyrates; Immunosuppressive Agents; Interleukin-1; Isoxazoles; Kupffer Cells; Leflunomide; Lipopolysaccharides; Male; Nitriles; Rats; Rats, Sprague-Dawley; Toluidines; Tumor Necrosis Factor-alpha

2004
A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells.
    Inflammation, 2004, Volume: 28, Issue:2

    Topics: Aniline Compounds; Animals; Cell Communication; Cell Survival; Cells, Cultured; Coculture Techniques; Crotonates; Hepatitis; Hepatocytes; Hydroxybutyrates; Immunosuppressive Agents; Interleukin-1; Isoxazoles; Kupffer Cells; Leflunomide; Lipopolysaccharides; Male; Nitriles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Toluidines; Tumor Necrosis Factor-alpha

2004
Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB.
    Hepatology (Baltimore, Md.), 2004, Volume: 40, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Caspase Inhibitors; Cells, Cultured; Concanavalin A; Cytokines; Enzyme Activation; Hepatitis; Interferon-gamma; Interleukin-2; Isoxazoles; Leflunomide; Liver; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; RNA, Messenger; T-Lymphocytes; Tumor Necrosis Factor-alpha

2004